Cargando…
Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
BACKGROUND: Glycogen storage disease type Ib (GSD Ib) is a rare inborn error of glycogen metabolism due to mutations in SLC37A4. Besides a severe form of fasting intolerance, the disorder is usually associated with neutropenia and neutrophil dysfunction causing serious infections, inflammatory bowel...
Autores principales: | Grünert, Sarah C., Elling, Roland, Maag, Bärbel, Wortmann, Saskia B., Derks, Terry G. J., Hannibal, Luciana, Schumann, Anke, Rosenbaum-Fabian, Stefanie, Spiekerkoetter, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446198/ https://www.ncbi.nlm.nih.gov/pubmed/32838757 http://dx.doi.org/10.1186/s13023-020-01503-8 |
Ejemplares similares
-
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
por: Grünert, Sarah Catharina, et al.
Publicado: (2022) -
Successful pregnancy in a woman with glycogen storage disease type 6
por: Grünert, Sarah Catharina, et al.
Publicado: (2021) -
Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023) -
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI
por: Grünert, Sarah Catharina, et al.
Publicado: (2021) -
Three successful pregnancies in a patient with glycogen storage disease type 0
por: Grünert, Sarah C., et al.
Publicado: (2020)